Accordingly, three patients with SLC52A3 mutation exhibited increased plasma acylcarnitines and urine organic acids, and mimicked an inherited disorder affecting mitochondrial fatty acid β-oxidation: i.e. multiple acyl-CoA dehydrogenase deficiency (MADD). Here, SLC52A3 is linked to multiple acyl-CoA dehydrogenase deficiency.